These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23271467)

  • 1. Chiral peptide nucleic acids with a substituent in the N-(2-aminoethy)glycine backbone.
    Sugiyama T; Kittaka A
    Molecules; 2012 Dec; 18(1):287-310. PubMed ID: 23271467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
    Gambari R
    Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide nucleic acids: Advanced tools for biomedical applications.
    Gupta A; Mishra A; Puri N
    J Biotechnol; 2017 Oct; 259():148-159. PubMed ID: 28764969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The peptide nucleic acids (PNAs): "high-tech" probes for genetic and molecular cytogenetic investigations].
    Pellestor F; Paulasova P; Macek M; Hamamah S
    Med Sci (Paris); 2005; 21(8-9):753-8. PubMed ID: 16115462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side chain modified peptide nucleic acids (PNA) for knock-down of six3 in medaka embryos.
    Dorn S; Aghaallaei N; Jung G; Bajoghli B; Werner B; Bock H; Lindhorst T; Czerny T
    BMC Biotechnol; 2012 Aug; 12():50. PubMed ID: 22901024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.
    Penolazzi L; Borgatti M; Lambertini E; Mischiati C; Finotti A; Romanelli A; Saviano M; Pedone C; Piva R; Gambari R
    Int J Mol Med; 2004 Aug; 14(2):145-52. PubMed ID: 15254756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pendant chiral C(γ)-(alkylideneamino/guanidino) cationic side-chains of PNA backbone on hybridization with complementary DNA/RNA and cell permeability.
    Jain DR; Anandi V L; Lahiri M; Ganesh KN
    J Org Chem; 2014 Oct; 79(20):9567-77. PubMed ID: 25221945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide nucleic acid conjugates: synthesis, properties and applications.
    Zhilina ZV; Ziemba AJ; Ebbinghaus SW
    Curr Top Med Chem; 2005; 5(12):1119-31. PubMed ID: 16248787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.
    Pellestor F; Paulasova P
    Chromosoma; 2004 Jun; 112(8):375-80. PubMed ID: 15156326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide Nucleic Acids: Recent Developments in the Synthesis and Backbone Modifications.
    Singh G; Monga V
    Bioorg Chem; 2023 Dec; 141():106860. PubMed ID: 37748328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into peptide nucleic acid (PNA) structural features: the crystal structure of a D-lysine-based chiral PNA-DNA duplex.
    Menchise V; De Simone G; Tedeschi T; Corradini R; Sforza S; Marchelli R; Capasso D; Saviano M; Pedone C
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12021-6. PubMed ID: 14512516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of peptide nucleic acid with modifications of its backbone and application in biotechnology.
    Das A; Pradhan B
    Chem Biol Drug Des; 2021 Apr; 97(4):865-892. PubMed ID: 33314595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and purification of peptide nucleic acids.
    Braasch DA; Nulf CJ; Corey DR
    Curr Protoc Nucleic Acid Chem; 2002 Aug; Chapter 4():Unit 4.11. PubMed ID: 18428893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
    Pradeep SP; Malik S; Slack FJ; Bahal R
    RNA; 2023 Apr; 29(4):434-445. PubMed ID: 36653113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide nucleic acids and their potential applications in biotechnology.
    Buchardt O; Egholm M; Berg RH; Nielsen PE
    Trends Biotechnol; 1993 Sep; 11(9):384-6. PubMed ID: 7691090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and hybridization of novel chiral pyrrolidine based PNA analogue.
    Slaitas A; Yeheskiely E
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1377-9. PubMed ID: 11563026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolidinyl PNA with α/β-Dipeptide Backbone: From Development to Applications.
    Vilaivan T
    Acc Chem Res; 2015 Jun; 48(6):1645-56. PubMed ID: 26022340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorous Peptide Nucleic Acids: PNA Analogues with Fluorine in Backbone (γ-CF2-apg-PNA) Enhance Cellular Uptake.
    Ellipilli S; Ganesh KN
    J Org Chem; 2015 Sep; 80(18):9185-91. PubMed ID: 26322827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peptide nucleic acids (PNAs): a new generation of probes for genetic and cytogenetic analyses.
    Paulasova P; Pellestor F
    Ann Genet; 2004; 47(4):349-58. PubMed ID: 15581832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ Sulphate PNA (PNA S): highly selective DNA binding molecule showing promising antigene activity.
    Avitabile C; Moggio L; Malgieri G; Capasso D; Di Gaetano S; Saviano M; Pedone C; Romanelli A
    PLoS One; 2012; 7(5):e35774. PubMed ID: 22586450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.